Avidity Biosciences Inc

NASDAQ:RNA   10:34:23 AM EDT
21.80
+0.88 (+4.21%)
Earnings Announcements

Avidity Biosciences Reports Fourth Quarter And Year-End 2020 Financial Results

Published: 03/15/2021 20:55 GMT
Avidity Biosciences Inc (RNA) - Avidity Biosciences Reports Fourth Quarter and Year-end 2020 Financial Results and Recent Highlights.
Qtrly Net Loss per Share $0.43.
Q4 Earnings per Share View $-0.34 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $1.83 Million
Adjusted EPS is expected to be -$0.72

Next Quarter Revenue Guidance is expected to be $1.83 Million
Next Quarter EPS Guidance is expected to be -$0.81

More details on our Analysts Page.